Top 37 Effector Therapeutics investors
The most complete profiles first. Showing 37 of 37.
David GoeddelVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Verified email available
Ken HaasVerified
Venture Capital, Advisor, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Kristen WongVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Constellation Pharmaceuticals, Cero Therapeutics, Encoded Therapeutics, Siluria Technologies and 19 more
Verified email available
Louis BernemanVerified
Venture Capital, University Program, Entrepreneurship Program · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Manny StockmanVerified
Venture Capital, University Program, Entrepreneurship Program · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Peter SvennilsonVerified
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Verified email available
Robert AdelsonVerified
Venture Capital, University Program, Investor · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 65 more
Verified email available
andrew sinclairVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Anurag AgarwalVerified
Venture Capital, University Program, Entrepreneurship Program · United States
Health CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Catherine PoulinVerified
Private Equity Firm, Investment Partner · Canada
Health CareInvestment ManagementLife ScienceEmerging MarketsPortfolio: HighLife, CurvaFix, Aprea, F2G and 19 more
Verified email available
Douglas CrawfordVerified
Venture Capital · United States
Health CareGeneticsWellnessWomen FoundedPortfolio: Symbiome, Caribou Biosciences, Calithera Biosciences, Bolt Threads and 18 more
Verified email available
Jon RootVerified
Venture Capital · United States
Health CareCybersecurityWomen FoundedEnterprise SoftwarePortfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 61 more
Verified email available
Matt CohenVerified
Venture Capital, University Program · United States
Health CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Matthew FoyVerified
Corporate Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Semprus BioSciences, Pulmocide, Syntaxin, CRISPR Therapeutics and 50 more
Verified email available
Rick LewisVerified
Venture Capital · United States
Health CareCybersecurityWomen FoundedEnterprise SoftwarePortfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 61 more
Verified email available
Shelley ChuVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Steve KrauszVerified
Venture Capital · United States
Health CareCybersecurityWomen FoundedEnterprise SoftwarePortfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 66 more
Verified email available
Tim HainesVerified
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Bali Muralidhar
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 69 more
Contact details available
Brian Gallagher, Jr.
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Aileron Therapeutics, Amarin and 67 more
Contact details available
Dave Maki
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Constellation Pharmaceuticals, Cero Therapeutics, Encoded Therapeutics, Siluria Technologies and 19 more
Contact details available
Jacques Benkoski
Venture Capital, Strategy Operator, CEO · United States
Series AHealth CareCybersecurityWomen FoundedEnterprise SoftwarePortfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 64 more
Contact details available
Kurt von Emster
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedInvestment ManagementLife SciencePortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Maha Katabi, PhD, CFA
Hedge Fund, Venture Capital, Investor · Canada
SeedHealth CareGeneticsWomen FoundedInvestment ManagementPortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more
Contact details available
Marc Singer
Venture Capital, University Program, Entrepreneurship Program · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 69 more
Contact details available
Tim Kutzkey
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Contact details available
Vin Miles
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
William Harrington
Venture Capital, University Program, Investor · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 71 more
Contact details available
Alain J. Gilbert
Private Equity Firm, Investment Partner · France
Health CareInvestment ManagementLife ScienceEmerging MarketsPortfolio: HighLife, CurvaFix, Aprea, F2G and 19 more
Contact details available
Dafina Toncheva
Venture Capital · United States
Health CareCybersecurityWomen FoundedEnterprise SoftwarePortfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 64 more
Contact details available
JJ Kang
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Contact details available
James Evangelista
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Contact details available
John Heard
Venture Capital, Private Equity Firm · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Kirsten Leute
Venture Capital, University Program · United States
Health CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Contact details available
Marc
Private Equity Firm, Investment Partner · Canada
Health CareInvestment ManagementLife ScienceEmerging MarketsPortfolio: HighLife, CurvaFix, Aprea, F2G and 19 more
Contact details available
Robert Blazej
Venture Capital · United States
Health CareGeneticsWellnessWomen FoundedPortfolio: Symbiome, Caribou Biosciences, Calithera Biosciences, Bolt Threads and 18 more
Contact details available
Sarah Shackelton
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Effector Therapeutics investors are on Angel Roster?
Angel Roster lists 37 Effector Therapeutics investors. 18 of them (49%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (33), Private Equity Firms (13) and University Program Investors (8). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Effector Therapeutics investors invest in?
Among those that list a stage, the most common are Series A (6), Seed (6) and Series B (6).
Where are Effector Therapeutics investors based?
Most are based in the United States (27), the United Kingdom (6) and Canada (3).
Which companies have Effector Therapeutics investors backed?
The most-backed portfolio companies among them are Atsena Therapeutics (19), Q32 Bio (18), Ribon Therapeutics (18), Neuros Medical (16) and Escient Pharmaceuticals (13).
How do I contact Effector Therapeutics investors?
Create a free Angel Roster account to search and filter all 37, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.